awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37379962-D0864BDE-389B-4EC5-A0CA-FB67B595AE8B
Q37379962-D0864BDE-389B-4EC5-A0CA-FB67B595AE8B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37379962-D0864BDE-389B-4EC5-A0CA-FB67B595AE8B
Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal.
P2860
Q37379962-D0864BDE-389B-4EC5-A0CA-FB67B595AE8B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37379962-D0864BDE-389B-4EC5-A0CA-FB67B595AE8B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b085563328d89a2b3fab03cddd175af5a0ca8861
P2860
Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.